Description of Research Group
The proteomics group at IBV provides service and performs independent research on cancer proteomics. The major aim of my group is the application and development of proteomics technology to analyze anti-cancer drug
action, to discover and validate novel protein biomarkers for the diagnosis and prognosis of cancer and to characterize therapeutic proteins in-depth.
Technology, expertise and equipment
- LC-MS based qualitative and quantitative proteomics
- Analysis of posttranslational modifications
- MALDI-MS and LC-ESI-MS